Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 20 studies | 63% ± 14% | |
lung | 18 studies | 64% ± 15% | |
intestine | 13 studies | 57% ± 25% | |
brain | 11 studies | 36% ± 14% | |
kidney | 9 studies | 65% ± 14% | |
eye | 9 studies | 47% ± 20% | |
liver | 7 studies | 53% ± 27% | |
bone marrow | 6 studies | 49% ± 18% | |
lymph node | 6 studies | 64% ± 16% | |
pancreas | 5 studies | 63% ± 20% | |
uterus | 5 studies | 63% ± 24% | |
placenta | 4 studies | 70% ± 19% | |
prostate | 4 studies | 52% ± 14% | |
breast | 4 studies | 60% ± 11% | |
heart | 3 studies | 34% ± 14% | |
adrenal gland | 3 studies | 57% ± 12% | |
esophagus | 3 studies | 67% ± 26% | |
skin | 3 studies | 50% ± 18% | |
thymus | 3 studies | 71% ± 24% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 4521.53 | 258 / 258 | 100% | 373.27 | 230 / 230 |
esophagus | 100% | 5895.21 | 1445 / 1445 | 100% | 316.00 | 183 / 183 |
ovary | 100% | 3425.34 | 180 / 180 | 100% | 693.46 | 430 / 430 |
skin | 100% | 4985.18 | 1809 / 1809 | 100% | 420.96 | 472 / 472 |
thymus | 100% | 4376.55 | 653 / 653 | 100% | 389.17 | 605 / 605 |
uterus | 100% | 3680.31 | 170 / 170 | 100% | 573.02 | 459 / 459 |
brain | 100% | 5838.53 | 2639 / 2642 | 100% | 324.51 | 704 / 705 |
kidney | 100% | 7319.98 | 89 / 89 | 100% | 358.47 | 898 / 901 |
stomach | 100% | 5098.15 | 359 / 359 | 100% | 447.13 | 285 / 286 |
intestine | 100% | 6347.16 | 966 / 966 | 100% | 481.58 | 525 / 527 |
liver | 100% | 4303.05 | 225 / 226 | 100% | 489.88 | 406 / 406 |
prostate | 100% | 4763.96 | 245 / 245 | 99% | 403.84 | 499 / 502 |
breast | 100% | 4445.76 | 459 / 459 | 99% | 400.62 | 1110 / 1118 |
bladder | 100% | 4786.43 | 21 / 21 | 99% | 518.48 | 500 / 504 |
pancreas | 99% | 2759.16 | 325 / 328 | 100% | 388.81 | 178 / 178 |
lung | 100% | 3864.63 | 576 / 578 | 99% | 394.82 | 1145 / 1155 |
adipose | 100% | 4658.03 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 526.28 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 625.64 | 29 / 29 |
muscle | 100% | 10161.97 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4300.35 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 431.98 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 597.96 | 1 / 1 |
blood vessel | 100% | 4527.21 | 1331 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 5570.49 | 926 / 929 | 0% | 0 | 0 / 0 |
heart | 100% | 13309.04 | 858 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1902600 | Biological process | proton transmembrane transport |
GO_0045333 | Biological process | cellular respiration |
GO_0021762 | Biological process | substantia nigra development |
GO_0006123 | Biological process | mitochondrial electron transport, cytochrome c to oxygen |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0045277 | Cellular component | respiratory chain complex IV |
GO_0005751 | Cellular component | mitochondrial respiratory chain complex IV |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0004129 | Molecular function | cytochrome-c oxidase activity |
Gene name | COX6B1 |
Protein name | Cytochrome c oxidase subunit 6B1 (Cytochrome c oxidase subunit VIb isoform 1) (COX VIb-1) Cytochrome c oxidase subunit 6B1 (Cytochrome c oxidase subunit VIb isoform 1) |
Synonyms | COX6B |
Description | FUNCTION: Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over the inner membrane that drives transmembrane transport and the ATP synthase. Cytochrome c oxidase is the component of the respiratory chain that catalyzes the reduction of oxygen to water. Electrons originating from reduced cytochrome c in the intermembrane space (IMS) are transferred via the dinuclear copper A center (CU(A)) of subunit 2 and heme A of subunit 1 to the active site in subunit 1, a binuclear center (BNC) formed by heme A3 and copper B (CU(B)). The BNC reduces molecular oxygen to 2 water molecules using 4 electrons from cytochrome c in the IMS and 4 protons from the mitochondrial matrix. . |
Accessions | A0A494C160 ENST00000652250.1 P14854 ENST00000649813.2 K7EQD3 ENST00000392201.1 ENST00000590618.1 ENST00000592141.6 |